CreditRiskMonitor is a financial risk analysis and news service for credit, supply chain and financial professionals.  Our strength in coverage spans 58,000 global public companies, totaling about $70 trillion in corporate revenue.  We also offer solutions that can help ease private company financial risk assessment.  Leading corporations around the world – including more than 35% of the Fortune 1000, plus thousands more worldwide – rely on us to help them stay ahead of financial risk quickly, accurately and cost-effectively. 

A partial report preview for Rockwell Medical Inc is shown below.  Where indicated by "Yes," CreditRiskMonitor contains this information in its extensive database.  To get access to the full report and learn more about CreditRiskMonitor's robust financial risk analysis and timely news service, request a personalized demo and free trial today.

If you are already a subscriber and want to access the full report, click here.

Rockwell Medical Inc
30142 WIXOM ROAD
Phone: (248) 960-9009p:248 960-9009 WIXOM, MI  48393  United States Ticker: RMTIRMTI

Business Summary
Rockwell Medical, Inc. is a healthcare company that develops, manufactures, commercializes, and distributes a portfolio of hemodialysis products for dialysis providers around the world. It operates in the hemodialysis market, which involves the manufacture, sale and distribution of hemodialysis products to hemodialysis clinics, including pharmaceuticals, dialysis concentrates, dialysis kits and other ancillary products used in the dialysis process. It is the supplier of life-sustaining hemodialysis concentrates products to dialysis clinics. Its hemodialysis concentrates products are used to sustain a patient's life by removing toxins and balancing electrolytes in a dialysis patient’s bloodstream. Its first two branded products from its ferric pyrophosphate citrate (FPC) platform, Triferic (dialysate) and Triferic AVNU, are indicated to maintain hemoglobin in patients undergoing hemodialysis. It offers dry and liquid citric acid, acetic acid, and bicarbonate hemodialysis products.

Scores and Ratings
FRISK®
Score
Z''
Score
PAYCE®
Score
DBT
Index
Moody's
Rating
Fitch
Rating
DBRS
Rating
YesYes-Yes---

Financials, News and Filings
Latest
Statement
Last
Audit

News
SEC
Filings
Bankruptcy
Filings
Suit &
Judgment
Filings
Tax
Lien
Filings
9/30/202312/31/2022YesYes--Yes

Officers and Directors

Title

Name

Age
Title
Date
Start
Date
Independent Chairman of the Board Robert S.Radie 59 4/1/2022 3/31/2020
President, Chief Executive Officer, Director MarkStrobeck 52 7/1/2022 7/1/2022
Executive Vice President, Chief Legal Officer, Secretary MeganTimmins 50 9/1/2022 8/1/2021
6 additional Officers and Directors records available in full report.

Business Names
Business Name
Evoqua Concentrates
RMTI
Rockwell Medical India Private Limited

General Information
Number of Employees: 253 (As of 12/31/2022)
Outstanding Shares: 28,489,663 (As of 11/10/2023)
Shareholders: 37
Stock Exchange: NASD
Federal Tax Id: 383317208
Fax Number: (302) 655-5049
Email Address: rmtiir@aol.com


Copyright © 2024 CreditRiskMonitor.com (Ticker: CRMZ). All rights reserved.     
By using this website, you accept the Terms of Use Agreement.
Monday, March 18, 2024